The Registry of Toxic Effects of Chemical Substances
Cyclohexane, 1,2,3,4,5,6 - hexachloro - |
UPDATE: November 2004 | MW: 290.82 | MF: C6H6Cl6 |
SYNONYMS:
|
|
|
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
|
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
mutation in microorganisms
|
other microorganisms
|
100 mg/L (-enzymatic activation step)
|
MILEDM 5,103,1977
|
morphological transform
|
oral | rat
875 mg/kg/7 week- intermittent
|
CRNGDP 5,479,1984
|
|
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
oral | mouse
lowest published toxic dose: 9,120 mg/kg (22 week male)
|
Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count)
|
BECTA6 26,508,1981
|
oral | mouse
lowest published toxic dose: 5,460 mg/kg (91 day male)
|
Reproductive: Paternal effects: Testes, epididymis, sperm duct
|
BECTA6 23,431,1979
|
oral | rat
lowest published toxic dose: 8,100 mg/kg (90 day male)
|
Reproductive: Paternal effects: Testes, epididymis, sperm duct
|
APTOA6 52,12,1983
|
|
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
oral | mouse
lowest published toxic dose: 6,720 mg/kg/80 week- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Liver: Tumors Blood: Tumors
JPFCD2 14,305,1979
|
oral | mouse
toxic dose : 800 mg/kg/80 week- intermittent
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Liver: Tumors Blood: Tumors
JPFCD2 14,305,1979
|
oral | mouse
toxic dose : 12,600 mg/kg/30 week- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Liver: Tumors
JCROD7 99,143,1981
|
oral | mouse
toxic dose : 12,960 mg/kg/26 week- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Liver: Tumors
CMSHAF 1,279,1972
|
oral | mouse
toxic dose : 21,600 mg/kg/52 week- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Liver: Tumors
TUMOAB 69,383,1983
|
oral | mouse
toxic dose : 5,400 mg/kg/13 week- continuous
|
Tumorigenic: Neoplastic by RTECS criteria | Liver: Tumors
TUMOAB 69,383,1983
|
oral | mouse
toxic dose : 7,200 mg/kg/17 week- continuous
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Liver: Tumors
IJEBA6 19,1159,1981
|
oral | mouse
toxic dose : 9 gm/kg/21 week- continuous
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Liver: Tumors
AEHLAU 37,156,1982
|
oral | mouse
toxic dose : 10,800 mg/kg/26 week- continuous
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Liver: Tumors
AEHLAU 37,156,1982
|
oral | mouse
toxic dose : 7,200 mg/kg/17 week- continuous
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Liver: Tumors
CMBID4 27,231,1981
|
oral | mouse
toxic dose : 10,800 mg/kg/26 week- continuous
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Liver: Tumors
CMBID4 27,231,1981
|
skin | mouse
lowest published toxic dose: 1,600 mg/kg/80 week- intermittent
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Liver: Tumors Blood: Tumors
JPFCD2 14,305,1979
|
|
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | cat
lowest published lethal concentration: 25 mg/m3/6 hour
|
N/R
|
VCVGH* -,537,1990
|
inhalation | man
lowest published toxic concentration: 400 µg/kg/3 day
|
Behavioral: Headache | Gastrointestinal: Nausea or vomiting Nutritional and Gross Metabolic: Body temperature increase
GISAAA 49(10),26,1984
|
inhalation | rat
lethal concentration (50 percent kill): 690 mg/m3/4 hour
|
N/R
|
GISAAA 56(2),80,1991
|
oral | wild bird
lethal dose (50 percent kill): 56 mg/kg
|
N/R
|
TXAPA9 21,315,1972
|
oral | cat
lethal dose (50 percent kill): 300 mg/kg
|
N/R
|
VCVGH* -,537,1990
|
oral | chicken
lethal dose (50 percent kill): 597 mg/kg
|
Peripheral Nerve and Sensation: Flaccid paralysis without anesthesia (usually neuromuscular blockage) | Behavioral: Convulsions or effect on seizure threshold Behavioral: Ataxia
POSCAL 60,2599,1981
|
oral | guinea pig
lowest published lethal dose: 1,400 mg/kg
|
N/R
|
MEMOAQ 4,25,1950
|
oral | mouse
lethal dose (50 percent kill): 59 mg/kg
|
N/R
|
PEMNDP 9,452,1991
|
oral | quail
lethal dose (50 percent kill): 120 mg/kg
|
N/R
|
PEMNDP 9,452,1991
|
oral | rat
lethal dose (50 percent kill): 100 mg/kg
|
N/R
|
ATXKA8 22,115,1966
|
oral | rat
lowest published lethal dose: 400 mg/kg
|
N/R
|
VCVGH* -,537,1990
|
subcutaneous | rabbit
lethal dose (50 percent kill): 75 mg/kg
|
N/R
|
XPHPAW 414,273,1955
|
skin | rat
lethal dose (50 percent kill): 900 mg/kg
|
N/R
|
85DPAN -,-,1971/1976
|
|
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intraperitoneal | rabbit
lowest published toxic dose: 650 mg/kg/65 week- intermittent
|
Eye: Retinal changes pigmentary deposition, retinitis, other) | Nutritional and Gross Metabolic: Weight loss or decreased weight gain Nutritional and Gross Metabolic: Conditioned vitamin deficiency
JTOTDO 6,161,1987
|
oral | mouse
lowest published toxic dose: 750 mg/kg/15 day- intermittent
|
Liver: Other changes | Kidney, Ureter, and Bladder: Other changes Biochemical: Metabolism (intermediary): Other proteins
BECTA6 41,822,1988
|
oral | mouse
lowest published toxic dose: 13,104 mg/kg/26 week- continuous
|
Liver: Other changes | Liver: Tumors Liver: Changes in liver weight
CMSHAF 1,279,1972
|
oral | rat
lowest published toxic dose: 2,500 mg/kg/90 day- continuous
|
Liver: Other changes | Endocrine: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases
IJEBA6 19,1163,1981
|
oral | rat
lowest published toxic dose: 2,259 mg/kg/90 day- continuous
|
Behavioral: Tremor | Liver: Hepatitis (hepatocellular necrosis), diffuse Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
JAPTO* 21,75,2001
|
oral | rat
lowest published toxic dose: 4,500 mg/kg/90 day- continuous
|
Liver: Hepatitis (hepatocellular necrosis), diffuse | Blood: Changes in cell count (unspecified) Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects
JAPTO* 21,75,2001
|
skin | guinea pig
lowest published toxic dose: 3 gm/kg/30 day- intermittent
|
Liver: Fatty liver degeneration | Kidney, Ureter, and Bladder: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects
JTOTDO 11,3,1992
|
skin | rat
lowest published toxic dose: 6,000 mg/kg/120 day- intermittent
|
Endocrine: Androgenic | Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count) Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects
HETOEA 14,484,1995
|
|
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
International Agency for Research on Cancer (IARC) Cancer Review
|
Animal Sufficient Evidence
|
IMEMDT 5,47,1974
|
TOXICOLOGY REVIEW
|
|
AABIAV 35,505,1948
|
TOXICOLOGY REVIEW
|
|
ECMAAI 14,141,1973
|
|
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
Occupational Exposure Limit - AUSTRALIA
|
time-weighted average 0.5 mg/m3, Skin, JAN1993
|
Occupational Exposure Limit - BELGIUM
|
time-weighted average 0.5 mg/m3, Skin, JAN1993
|
Occupational Exposure Limit - DENMARK
|
time-weighted average 0.5 mg/m3, Skin, JAN1999
|
Occupational Exposure Limit - FINLAND
|
time-weighted average 0.5 mg/m3, Skin, Carcinogen, JAN1999
|
Occupational Exposure Limit - FRANCE
|
VME 0.5 mg/m3, Skin, JAN1993
|
Occupational Exposure Limit - GERMANY
|
MAK 0.5 mg/m3, Skin, JAN1999
|
Occupational Exposure Limit - HUNGARY
|
time-weighted average 0.5 mg/m3, short term exposure limit 0.1 mg/m3, Skin, JAN1993
|
Occupational Exposure Limit - POLAND
|
MAC(time-weighted average) 0.05 mg/m3, MAC(short term exposure limit) 0.4 mg/m3, JAN1999
|
Occupational Exposure Limit - RUSSIA
|
short term exposure limit 0.05 mg/m3, Skin, JAN1993
|
Occupational Exposure Limit - RUSSIA
|
short term exposure limit 0.1 mg/m3, Skin, JAN1993
|
Occupational Exposure Limit - SWITZERLAND
|
MAK- week 0.5 mg/m3, Skin, JAN1999
|
Occupational Exposure Limit - UNITED KINGDOM
|
LTEL 0.5 mg/m3, short term exposure limit 1.5 mg/m3, Skin, JAN1993
|
|
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
N/R
|
N/R
|
N/R
|
|
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
EPA TSCA Section 8(d) unpublished health/safety studies
|
On EPA IRIS database
|
EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001
|
NTP 10th Report on Carcinogens,2002:Reasonably anticipated to be a human carcinogen
|
|
REFERENCES:
CODEN
|
|
REFERENCE
85DPAN
|
"Wirksubstanzen der Pflanzenschutz und Schadlingsbekampfungsmittel," Perkow, W., Berlin,
Verlag Paul Parey, 1971-1976
|
AABIAV
|
Annals of Applied Biology. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester,
Essex CO2 8HP, UK) V.1- 1914-
|
AEHLAU
|
Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC
20016) V.1- 1960-
|
APTOA6
|
Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher
information, see PHTOEH
|
ATXKA8
|
Archiv fuer Toxikologie. (Berlin, Fed. Rep. Ger.) V.15-31, 1954-74. For publisher
information, see ARTODN.
|
BECTA6
|
Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc.,
Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966-
|
CMBID4
|
Cellular and Molecular Biology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford,
NY 10523) V.22- 1977-
|
CMSHAF
|
Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1-
1972-
|
CRNGDP
|
Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford
OX8 1JJ, UK) V.1- 1980-
|
ECMAAI
|
Economie et Medecine Animales. (Paris, France) V.1-17, 1960-76. Discontinued.
|
GISAAA
|
Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga,
113095 Moscow, USSR) V.1- 1936-
|
HETOEA
|
Human & Experimental Toxicology. (Macmillan Press Ltd., Brunel Road, Houndmills, Basingstoke,
Hampshire, RG21 2XS, UK) V.9- 1990-
|
IJEBA6
|
Indian Journal of Experimental Biology. (Publications & Information Directorate, CSIR,
Hillside Rd., New Delhi 110 012, India) V.1- 1963-
|
IMEMDT
|
IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications
Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972-
|
JAPTO*
|
Journal of Applied Toxicology (John Wiley & Sons, Ltd., Oldlands Way Bognor Regis West Sussex,
PO22 9SA England) V.1- 1981-
|
JCROD7
|
Journal of Cancer Research and Clinical Oncology. (Springer-Verlag New York, Inc., Service
Center, 44 Hartz Way, Secaucus, NJ 07094) V.93- 1979-
|
JPFCD2
|
Journal of Environmental Science and Health, Part B: Pesticides, Food Contaminants, and
Agricultural Wastes. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.B11- 1976-
|
JTOTDO
|
Journal of Toxicology, Cutaneous and Ocular Toxicology. (Marcel Dekker, 270 Madison Ave., New
York, NY 10016) V.1- 1982-
|
MEMOAQ
|
Medizinische Monatsschrift. (Stuttgart, Fed. Rep. Ger.) V.1-31, 1947-77.
|
MILEDM
|
Microbios Letters. (Faculty Press, 88 Regent St., Cambridge, UK) V.1- 1976-
|
PEMNDP
|
Pesticide Manual. (The British Crop Protection Council, 20 Bridport Rd., Thornton Heath CR4
7QG, UK) V.1- 1968-
|
POSCAL
|
Poultry Science. (Poultry Science Assoc., Inc., 309 W. Clark St., Champaign, IL 61820) V.1-
1921-
|
TUMOAB
|
Tumori. (Casa Editrice Ambrosiana, Via G. Frua 6, 20146 Milan, Italy) V.1- 1911-
|
TXAPA9
|
Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802)
V.1- 1959-
|
VCVGH*
|
"Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances:
Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990.
|
XPHPAW
|
U.S. Public Health Service Publication. (U.S. Government Printing Office, Supt. of Documents,
Washington, DC 20402) No.1- 1950-
|
|